Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
Hang Li,1,2,* Haichuan Hu,1,2,* Rui Wang,1,2 Yunjian Pan,1,2 Lei Wang,1,2 Yuan Li,2,3 Yang Zhang,1,2 Ting Ye,1,2 Yiliang Zhang,1,2 Bin Li,1,2 Lei Shen,2,3 Yihua Sun,1,2 Haiquan Chen1,2 1Department of Thoracic Surgery, 2Department of Oncology, 3Department of Pathology, Shanghai Medical College, Fuda...
Main Authors: | Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Li B, Shen L, Sun Y, Chen H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-04-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/primary-concomitant-egfr-t790m-mutation-predicted-worse-prognosis-in-n-a16329 |
Similar Items
-
Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
by: Gao X, et al.
Published: (2019-11-01) -
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs
by: Liu Y, et al.
Published: (2017-04-01) -
Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations
by: Zhang Y, et al.
Published: (2021-04-01) -
Highly Sensitive Droplet Digital PCR Method for Detection of de novo EGFR T790M Mutation in Patients with Non-Small Cell Lung Cancer
by: Wang X, et al.
Published: (2020-10-01) -
Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
by: Yamane H, et al.
Published: (2013-03-01)